[Fibrinolysis modulators]
- PMID: 12583322
[Fibrinolysis modulators]
Abstract
The structure of fibrin network and the properties of the fibrinolytic enzymes (the formation, the efficiency of their activity and the rate of their inactivation) essentially determine the effectiveness of fibrinolysis. The fibrin structure and the action of proteases, however, depend considerably on additional physiological and pathological conditions. These are: cell membrane and components of endothelial cell, elastase of polymorphonuclear cells, actin and myosin in thrombus released by platelets and smooth muscle cells, certain denatured proteins, various immunoglobulins, some metabolites accumulated in diabetes mellitus, the inhibitor system of fibrinolytic enzymes (where and when proteases are available for inhibitors). In this survey, the biochemical basis makes understandable for the medical practitioner why urgent fibrinolytic therapy is required and why it would be ideal to initiate the formation of fibrinolytic enzymes at the site of thrombus.
Similar articles
-
Molecular and cellular modulation of fibrinolysis.Thromb Haemost. 2003 Apr;89(4):610-21. Thromb Haemost. 2003. PMID: 12669114 Review.
-
[Plasminogen activation and regulation of fibrinolysis].Nihon Rinsho. 2014 Jul;72(7):1218-23. Nihon Rinsho. 2014. PMID: 25163311 Review. Japanese.
-
Plasminogen activators: pharmacology and therapy.Radiology. 1990 Mar;174(3 Pt 2):993-1001. doi: 10.1148/radiology.174.3.174-3-993. Radiology. 1990. PMID: 2137641 Review.
-
[Endothelium, thrombosis and fibrinolysis].Rev Prat. 1997 Dec 15;47(20):2227-31. Rev Prat. 1997. PMID: 9616910 Review. French.
-
Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.Crit Care Med. 2003 Apr;31(4 Suppl):S213-20. doi: 10.1097/01.CCM.0000057846.21303.AB. Crit Care Med. 2003. PMID: 12682443 Review.